Estimates when and where a model-guided treatment strategy may outperform a treat-all or treat-none approach by Monte Carlo simulation and evaluation of the Net Monetary Benefit. Details can be viewed in Parsons et al. (2023) <doi:10.21105/joss.05328>.
copied from cf-staging / r-predictnmb| Label | Latest Version |
|---|---|
| main | 0.2.1 |
